摘要
目的:观察芪蚣抗纤方(QF)拆方中软坚散结药(蜈蚣、山慈姑)对免疫损伤性肝纤维化大鼠TGFβ-1定性定量表达的影响。方法:猪血清攻击法诱导免疫损伤性肝纤维化大鼠模型,随机分为模型组、软坚散结药大剂量干预组、软坚散结药小剂量干预组,另设正常对照组,整个实验过程共8周。免疫组化法检测肝组织TGF-β1相关表达;酶标仪ABC-ELISA法测血清TGF-β1含量。结果:免疫组化显示:正常组大鼠肝脏仅TGFβ1微弱表达,模型组较正常组TGFβ1阳性信号明显增强(P<0.01),软坚散结药干预后大鼠肝脏TGFβ1表达比模型组明显下调,(小剂量P<0.01,大剂量P<0.05),大、小剂量组与模型组相比有差异。血清TGF-β1含量:与模型组相比,软坚散结药大、小剂量干预后动物血清中的TGFβl显著降低(P<0.01)。结论:芪蚣抗纤方(QF)中软坚散结药大、小剂量对免疫损伤性大鼠肝纤维化形成和逆转均有影响,对促肝纤维化细胞因子TGFβ-1均有很好调节作用,对临床上应用软坚散结药治疗肝纤维化有一定的指导意义。
Objective: To observe influence of Wugong and Shancigu in Qi ,Gong Kang Xian formu- la (QF) on expression of TGFβ-1 in rat model of liver fibrosis induced by immune damage. Methods: Rat models of liver fibrosis induced by immune damage were established with porcine serum attack method, and randomly divided into model group, high-dose group and low-dose group, healnEh rats were also used as normal control group. After 8 weeks of treatment, TGF-β1 expression was determined with immunohistochemical assay, and TGF-β1 concentration was evaluated with Microplate reader ABC-ELISA method. Resuits: Immunohistochemistry revealed expression of TGF-β1 was weak in normal control group, and obviously increased in model rats; however, the increased expression of TGF-β1 were down regulated in both high-dose and low dose groups, more obviously in low-dose group (P〈0.01) than that in high-dose group (P〈0.05). Serum TGF-β1 concentration was significantly decreased in both high-dose and low dose group comparing with that in the model group (P〈0.01). Conclusions: Both high and low dose of Softening and Resolving Hard Mass herbs in QF show effects on liver fibrosis and can regulate liver fibrosis cytokine TGFβ-1, this study confirmed the effects of Softening and Resolving Hard Mass herbs for hepatic fibrosis.
出处
《海南医学院学报》
CAS
2012年第9期1173-1176,共4页
Journal of Hainan Medical University
基金
2008年海南省自然科学基金资助项目(NO.808165)~~
关键词
软坚散结药
肝纤维化
TGFβ—1
Softening and Resolving Hard Mass herb
Liver fibrosis
TGFβ-1